lab to market funding solutions for the valley of opportunity · o one stop solution for granting,...
TRANSCRIPT
01
Lab to Market Funding Solutions for the Valley of Opportunity
Benefunder Ecosystem
Curated, relationship-driven alignment of philanthropy and investment with research and commercial
opportunities
Philanthropists&
Investors
Researchers &
Entrepreneurs
Wealth Management
DAF AdminsResearch
Institutions
Accelerators & Incubators
o One stop solution for Granting, Gifting and Impact Investing.
o Significantly alignment, transparency, & efficiency for funders.
o Access to a large and diverse group of philanthropists & impact investors.
o Ongoing engagement via reporting, communication and access to recipients
post funding.
o Significantly reduced time/resource requirements for researchers &
entrepreneurs.
o Funding opportunities across all cause areas.
o Pre-negotiated low overhead funding terms – success based.
o Funding across all stages of Lab to Market.
Benefunder
The Benefunder Solution 03
Benefunder Philanthropic Services
Benefunder Capital Markets
Pre-Seed Series ASeed
GrowthValidationCommercializationResearch
Gift/Grant Series B… Exit
Efficient & Aligned Continuum of Capital
08Scale – Technology Enabled Services
CMSUser Interfaces
Profile ManagementFINRA Approved
CRMData ManagementCommunications
Reporting
AIMatchmaking
Funders – Funding Opportunities
Diligence
API’s3rd Party Data
Channel DistributionPartner Integration
Workflow and Process Automation for Scale
Who’s With Us?
Traction18
700 Researchers Signed/Profiled
12 Institution Partners
Channel Partners
Sourcing, Diligence, & Vetting
Current MandatesFocus Area Philanthropy/Investment Capacity Status
Autism/ Dyslexia/ Disadvantaged Youth
Investment $60M Active
Clean Energy Blended $5M ActiveDiabetes/Clean Water Philanthropy $2M Active
Veterans Philanthropy $1M Active
Opportunistic Impact Investment $300M Fund Active
Life Science/Cybersecurity Blended $150M Developing
Autism/ Digital Health Blended $100M Fund Developing
Rare Disease Blended $2M Developing
Microbiome/Regenerative Blended $250M DevelopingWomen’s Health Blended $5M DevelopingOpportunistic Impact Investment $2B Fund Developing
Validation - Impact 03
No Engagement
No TransparencyNo Control
Funding TermsRFPScientific Board
Engagement 90%
Public Charity
Private Foundation
< 20%
<50%
Access Efficiency
Time Spent
Fundraising
60%Teaching
15%
Peer Review
10%
Research15%
Fundraising10% Teachi
ng15%
Peer Review
10%
Research
65%